Isoproterenol-mediated heme oxygenase-1 induction inhibits high mobility group box 1 protein release and protects against rat myocardial ischemia/reperfusion injury in vivo

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1863-1868

  Wang, Jichun ^a   Hu, Xiaorong ^a   Fu, Wenwen ^a   Xie, Jing ^a   Zhou, Xiaoya ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Heme oxygenase 1; High mobility group box 1 protein; Isoproterenol; Myocardial ischemia and reperfusion

Indexed keywords

CREATINE KINASE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; ISOPRENALINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTOPORPHYRIN ZINC; PROTOPORPHYRIN ZINC IX; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REPERFUSION INJURY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CREATINE KINASE; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HEMODYNAMICS; HMGB1 PROTEIN; INTERLEUKIN-6; ISOPROTERENOL; LACTATE DEHYDROGENASES; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899501011     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2026     Document Type: Article

References (32)

1. Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005. (Pubitemid 40516158)
2. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L and Stahl GL: Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97: 2259-2267, 1998. (Pubitemid 28265388)
3. Frangogiannis NG, Smith CW and Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002. (Pubitemid 34020764)
4. Andrassy M, Volz HC, Igwe JC, et al: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216-3226, 2008.
5. Hu X, Fu W and Jiang H: HMGB1: a potential therapeutic target for myocardial ischemia and reperfusion injury. Int J Cardiol 155: 489, 2012.
6. Otterbein LE, Soares MP, Yamashita K and Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455, 2003. (Pubitemid 36928103)
7. Hwa JS, Jin YC, Lee YS, et al: 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. J Ethnopharmacol 139: 605-615, 2012.
8. Liu SX, Zhang Y, Wang YF, et al: Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes. Int J Cardiol 160: 95-101, 2012.
9. 1-adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice. Biochem Pharmacol 82: 769-777, 2011.
10. Jin YC, Kim CW, Kim YM, et al: Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-α-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur J Pharmacol 614: 91-97, 2009.
11. Wang J, Yang H, Hu X, et al: Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo. J Surg Res 183: 509-516, 2013.
12. Yan L, Tang Q, Shen D, et al: SOCS-1 inhibits TNF-α-induced cardiomyocyte apoptosis via ERK1/2 pathway activation. Inflammation 31: 180-188, 2008.
13. Yang J, Jiang H, Yang J, Ding JW, Chen LH, Li S and Zhang XD: Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-κB signaling pathway. Mol Cell Biochem 330: 39-46, 2009.
14. Inoue K, Kawahara K, Biswas KK, et al: HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol 16: 136-143, 2007. (Pubitemid 46729668)
15. Arroyo-Espliguero R, Avanzas P, Quiles J and Kaski JC: Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 204: 239-243, 2009.
16. Andersson U, Wang H, Palmblad K, et al: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565-570, 2000. (Pubitemid 30666257)
17. Takamiya R, Hung CC, Hall SR, et al: High-mobility group box 1 contributes to lethality of endotoxemia in heme oxygenase-1-deficient mice. Am J Respir Cell Mol Biol 41: 129-135, 2009.
18. Tsoyi K, Lee TY, Lee YS, et al: Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo. Mol Pharmacol 76: 173-182, 2009.
19. 2-adrenoreceptor activation. Am J Physiol 273: E1203-E1208, 1997.
20. Kappel M, Poulsen TD, Galbo H and Pedersen BK: Effects of elevated plasma noradrenaline concentration on the immune system in humans. Eur J Appl Physiol Occup Physiol 79: 93-98, 1998. (Pubitemid 29041379)
21. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA and Street NE: Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158: 4200-4210, 1997. (Pubitemid 127483920)
22. Muthu K, He LK, Szilagyi A, Strotmon P, Gamelli RL and Shankar R: β-adrenergic stimulation increases macrophage CD14 expression and E. coli phagocytosis through PKA signaling mechanisms. J Leukoc Biol 88: 715-724, 2010.
23. Liu S, Morris SM Jr, Nie S, Shapiro RA and Billiar TR: cAMP induces CD14 expression in murine macrophages via increased transcription. J Leukoc Biol 67: 894-901, 2000.
24. Gegner JA, Ulevitch RJ and Tobias PS: Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 270: 5320-5325, 1995.
25. Tsung A, Klune JR, Zhang X, et al: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204: 2913-2923, 2007. (Pubitemid 350179560)
26. 2-induced cardiomyocyte death through suppression of high-mobility group box 1. Mol Cell Biochem 364: 263-269, 2012.
27. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V and Forman HJ: HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med 39: 355-364, 2005. (Pubitemid 40910192)
28. Ryter SW and Choi AM: Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal 7: 80-91, 2005. (Pubitemid 40187927)
29. Eom HW, Park SY, Kim YH, et al: Bambusae Caulis in Taeniam modulates neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via HO-1- and Nrf-2-mediated pathways. Int J Mol Med 30: 1512-1520, 2012.
30. Jin GH, Park SY, Kim E, et al: Anti-inflammatory activity of Bambusae Caulis in Taeniam through heme oxygenase-1 expression via Nrf-2 and p38 MAPK signaling in macrophages. Environ Toxicol Pharmacol 34: 315-323, 2012.
31. Senthil Kumar KJ, Liao JW, Xiao JH, Gokila Vani M and Wang SY: Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes. Toxicol In Vitro 26: 700-708, 2012.
32. Ryu EY, Park AJ, Park SY, et al: Inhibitory effects of Ginkgo biloba extract on inflammatory mediator production by Porphyromonas gingivalis lipopolysaccharide in murine macrophages via Nrf-2 mediated heme oxygenase-1 signaling pathways. Inflammation 35: 1477-1486, 2012.